[Alpha-1-antitrypsin deficiency. An indication for pediatric liver transplantation]

A De Roover1, O Detry, P Honoré

  • 1Service de Chirurgie Abdominale et Transplantation, Université de Liège.

Revue Medicale De Liege
|January 16, 2002
PubMed

Insights

Alpha-1-antitrypsin deficiency is a common genetic disorder causing liver disease in children. Successful liver transplantation can restore health, allowing young patients to return to normal activities.

Area of Science:

  • Hepatology
  • Genetics
  • Pediatric Gastroenterology

Background:

  • Alpha-1-antitrypsin deficiency (AATD) is the most frequent inherited metabolic disorder impacting the liver.
  • It is the second leading indication for pediatric liver transplantation, following biliary atresia.

Observation:

  • A 6-year-old female presented with end-stage liver disease attributed to AATD.
  • The patient underwent a successful whole liver transplantation using a graft from a 3-year-old donor.

Findings:

  • The liver transplant effectively treated the end-stage liver disease caused by AATD.
  • The recipient experienced a positive recovery, returning to school within three months post-transplant.

Implications:

  • This case highlights liver transplantation as a viable and effective treatment for pediatric AATD.
  • Further understanding of AATD pathogenesis and natural history is crucial for managing affected children.